Physician profile
Varun Reddy
NPI 1013361484
$4,026.92
in general payments reported to CMS, 2019-2025
11 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.47 · 2021: $204 · 2022: $1,616 · 2023: $1,470 · 2024: $424 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,178.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,371.04 | 2022-2025 | Ic-8 Apthera Iol, Envista Mx60 Iol, Vyzulta |
| Abbvie INC. | $923.38 | 2022-2025 | |
| Iridex Corporation | $663.94 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $387.60 | 2021-2022 | |
| Alcon Vision LLC | $178.67 | 2022-2025 | Rocklatan, Simbrinza, Argos |
| Glaukos Corporation | $168.80 | 2023 | |
| Aveo Pharmaceuticals, INC. | $120.74 | 2021 | |
| Sight Sciences, INC. | $94.15 | 2021-2025 | Omni Surgical System |
| Penumbra, INC. | $74.47 | 2024 | Red 72 |
| Johnson & Johnson Vision Care, INC. | $28.47 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.66 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Varun Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.